Bid regulates the immunological profile of murine microglia and macrophages

GLIA

Volumn 59, Issue 3, 2011, Pages 397-412

  Mayo, Lior ^a   Levy, Ayelet ^a   Jacob Hirsch, Jasmine ^b   Amariglio, Ninette ^b   Rechavi, Gideon ^b   Stein, Reuven ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Bid; Inflammation; Macrophages; Microglia; Phagocytosis

Indexed keywords

BH3 PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN BID;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL PARAMETERS; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; SEPSIS;

ANIMALS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL LINE; CELLS, CULTURED; FEMALE; HEK293 CELLS; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NERVE DEGENERATION; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

EID: 78751693905     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21109     Document Type: Article

References (69)

1. Albrecht I, Tapmeier T, Zimmermann S, Frey M, Heeg K, Dalpke A. 2004. Toll-like receptors differentially induce nucleosome remodelling at the IL-12p40 promoter. EMBO Rep 5: 172-177.
2. Bermpohl D, You Z, Korsmeyer SJ, Moskowitz MA, Whalen MJ. 2006. Traumatic brain injury in mice deficient in Bid: Effects on histopathology and functional outcome. J Cereb Blood Flow Metab 26: 625-633.
3. Bruey JM, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, Xu C, Kress CL, Bailly-Maitre B, Li X, Osterman A, Matsuzawa S, Terskikh AV, Faustin B, Reed JC. 2007. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129: 45-56.
4. Cardona AE, Huang D, Sasse ME, Ransohoff RM. 2006. Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat Protoc 1: 1947-1951.
5. Cooper AM, Khader SA. 2007. IL-12p40: An inherently agonistic cytokine. Trends Immunol 28: 33-38.
6. Dihne M, Block F, Korr H, Topper R. 2001. Time course of glial proliferation and glial apoptosis following excitotoxic CNS injury. Brain Res 902: 178-189.
7. Egger L, Schneider J, Rheme C, Tapernoux M, Hacki J, Borner C. 2003. Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions. Cell Death Differ 10: 1188-1203.
8. Elkon R, Linhart C, Sharan R, Shamir R, Shiloh Y. 2003. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 13: 773-780.
9. Floden AM, Combs CK. 2006. Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J Neurosci 26: 4644-4648.
10. Galluzzi L, Joza N, Tasdemir E, Maiuri MC, Hengartner M, Abrams JM, Tavernarakis N, Penninger J, Madeo F, Kroemer G. 2008. No death without life: Vital functions of apoptotic effectors. Cell Death Differ 15: 1113-1123.
11. Garden GA, Moller T. 2006. Microglia biology in health and disease. J Neuroimmune Pharmacol 1: 127-137.
12. Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K. 2007. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 104: 18754-18759.
13. Green MM, Hutchison GJ, Valentine HR, Fitzmaurice RJ, Davidson SE, Hunter RD, Dive C, West CM, Stratford IJ. 2005. Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix. Br J Cancer 92: 449-458.
14. Gross A. 2006. BID as a double agent in cell life and death. Cell Cycle 5: 582-584.
15. Hanisch U-K, Kettenmann H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
16. Hickman SE, Allison EK, El Khoury J. 2008. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28: 8354-8360.
17. Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L, Haimovich G, Lerenthal Y, Marcellus RC, Gross A. 2005. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 122: 593-603.
18. Kang BY, Kim TS. 2006. Targeting cytokines of the interleukin-12 family in autoimmunity. Curr Med Chem 13: 1149-1156.
19. Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A, Waisman A, Brenner O, Haffner R, Gustafsson E, Ramakrishnan P, Lapidot T, Wallach D. 2004. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 173: 2976-2984.
20. Kaufmann T, Tai L, Ekert PG, Huang DC, Norris F, Lindemann RK, Johnstone RW, Dixit VM, Strasser A. 2007. The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell 129: 423-433.
21. Kim YS, Joh TH. 2006. Microglia, major player in the brain inflammation: Their roles in the pathogenesis of Parkinson's disease. Exp Mol Med 38: 333-347.
22. Klegeris A, McGeer PL. 1994. Rat brain microglia and peritoneal macrophages show similar responses to respiratory burst stimulants. J Neuroimmunol 53: 83-90.
23. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, Joshi BV, Jacobson KA, Kohsaka S, Inoue K. 2007. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446: 1091-1095.
24. Krajewska M, Zapata JM, Meinhold-Heerlein I, Hedayat H, Monks A, Bettendorf H, Shabaik A, Bubendorf L, Kallioniemi OP, Kim H, Reifenberger G, Reed JC, Krajewski S. 2002. Expression of Bcl-2 family member Bid in normal and malignant tissues. Neoplasia 4: 129-40.
25. Laham-Karam N, Bacharach E. 2007. Transduction of human immunodeficiency virus Type 1 vectors lacking encapsidation and dimerization signals. J Virol 81: 10687-10698.
26. Lakics V, Medvedev AE, Okada S, Vogel SN. 2000. Inhibition of LPS-induced cytokines by Bcl-xL in a murine macrophage cell line. J Immunol 165: 2729-2737.
27. Lee J, Hur J, Lee P, Kim JY, Cho N, Kim SY, Kim H, Lee MS, Suk K. 2001. Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells. Initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11. J Biol Chem 276: 32956-32965.
28. Lee L, Irani K, Finkel T. 1998. Bcl-2 regulates nonapoptotic signal transduction: Inhibition of c-Jun N-terminal kinase (JNK) activation by IL-1 beta and hydrogen peroxide. Mol Genet Metab 64: 19-24.
29. Lemstra AW, Groen in't Woud JC, Hoozemans JJ, van Haastert ES, Rozemuller AJ, Eikelenboom P, van Gool WA. 2007. Microglia activation in sepsis: A case-control study. J Neuroinflammation 4: 4.
30. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
31. Lukasiak S, Breuhahn K, Schiller C, Schmidtke G, Groettrup M. 2008. Quantitative analysis of gene expression relative to 18S rRNA in carcinoma samples using the LightCycler instrument and a SYBR GreenI-based assay: Determining FAT10 mRNA levels in hepatocellular carcinoma. Methods Mol Biol 429: 59-72.
32. Mankan AK, Lawless MW, Gray SG, Kelleher D, McManus R. 2009. NF-kappaB regulation: The nuclear response. J Cell Mol Med 13: 631-643.
33. Martin GS, Mannino DM, Eaton S, Moss M. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
34. Maruyama S, Sumita K, Shen H, Kanoh M, Xu X, Sato M, Matsumoto M, Shinomiya H, Asano Y. 2003. Identification of IFN regulatory factor-1 binding site in IL-12 p40 gene promoter. J Immunol 170: 997-1001.
35. Mayo L, Jacob-Hirsch J, Amariglio N, Rechavi G, Moutin MJ, Lund FE, Stein R. 2008. Dual role of CD38 in microglial activation and activation-induced cell death. J Immunol 181: 92-103.
36. Mayo L, Stein R. 2007. Characterization of LPS and interferon-gamma triggered activation-induced cell death in N9 and primary microglial cells: Induction of the mitochondrial gateway by nitric oxide. Cell Death Differ 14: 183-186.
37. Mosig S, Rennert K, Krause S, Kzhyshkowska J, Neunubel K, Heller R, Funke H. 2009. Different functions of monocyte subsets in familial hypercholesterolemia: Potential function of CD14+CD16+ monocytes in detoxification of oxidized LDL. FASEB J 23: 866-874.
38. Napoli I, Neumann H. 2009. Microglial clearance function in health and disease. Neuroscience 158: 1030-1038.
39. Ni HM, Baty CJ, Li N, Ding WX, Gao W, Li M, Chen X, Ma J, Michalopoulos GK, Yin XM. 2010. Bid agonist regulates murine hepatocyte proliferation by controlling endoplasmic reticulum calcium homeostasis. Hepatology 52: 338-348.
40. Paresce DM, Ghosh RN, Maxfield FR. 1996. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17: 553-565.
41. Pattyn F, Robbrecht P, De Paepe A, Speleman F, Vandesompele F. 2006. RTPrimerDB: The real-time PCR primer and probe database, major update 2006. Nucleic Acids Res 34: D684-D688.
42. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. 2007. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. GLIA 55: 453-462.
43. Richards S, Watanabe C, Santos L, Craxton A, Clark EA. 2008. Regulation of B-cell entry into the cell cycle. Immunol Rev 224: 183-200.
44. Righi M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani A, Donini SD, Ricciardi-Castagnoli P. 1989. Monokine production by microglial cell clones. Eur J Immunol 19: 1443-1448.
45. Robertson G, Bilenky M, Lin K, He A, Yuen W, Dagpinar M, Varhol R, Teague K, Griffith OL, Zhang X, Pan Y, Hassel M, Sleumer MC, Pan W, Pleasance ED, Chuang M, Hao H, Li YY, Robertson N, Fjell C, Li B, Montgomery SB, Astakhova T, Zhou J, Sander J, Siddiqui AS, Jones SJ. 2006. cisRED: A database system for genome-scale computational discovery of regulatory elements. Nucleic Acids Res 34: D68-D73.
46. Salkowski CA, Kopydlowski K, Blanco J, Cody MJ, McNally R, Vogel SN. 1999. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. J Immunol 163: 1529-1536.
47. Saura J, Tusell JM, Serratosa J. 2003. High-yield isolation of murine microglia by mild trypsinization. GLIA 44: 183-189.
48. Scatizzi JC, Hutcheson J, Bickel E, Haines GKIII, Perlman H. 2007. Pro-apoptotic Bid is required for the resolution of the effector phase of inflammatory arthritis. Arthritis Res Ther 9: R49.
49. Schmid CD, Melchior B, Masek K, Puntambekar SS, Danielson PE, Lo DD, Sutcliffe JG, Carson MJ. 2009. Differential gene expression in LPS/IFNgamma activated microglia and macrophages: In vitro versus in vivo. J Neurochem 109: 117-125.
50. Schmitt E, Paquet C, Beauchemin M, Bertrand R. 2007. DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis. J Zhejiang Univ Sci B 8: 377-397.
51. Schrijvers DM, Martinet W, De Meyer GR, Andries L, Herman AG, Kockx MM. 2004. Flow cytometric evaluation of a model for phagocytosis of cells undergoing apoptosis. J Immunol Methods 287: 101-108.
52. Schwartz M. 2003. Macrophages and microglia in central nervous system injury: Are they helpful or harmful? J Cereb Blood Flow Metab 23: 385-394.
53. Semmler A, Hermann S, Mormann F, Weberpals M, Paxian SA, Okulla T, Schafers M, Kummer MP, Klockgether T, Heneka MT. 2008. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation 5: 38.
54. Shamir R, Maron-Katz A, Tanay A, Linhart C, Steinfeld I, Sharan R, Shiloh Y, Elkon R. 2005. EXPANDER-An integrative program suite for microarray data analysis. BMC Bioinform 6: 232.
55. Sharan R, Shamir R. 2000. CLICK: A clustering algorithm with applications to gene expression analysis. Proc Int Conf Intell Syst Mol Biol 8: 307-316.
56. Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K. 2007. Microglia derived from aging mice exhibit an altered inflammatory profile. GLIA 55: 412-424.
57. Sordet O, Rebe C, Plenchette S, Zermati Y, Hermine O, Vainchenker W, Garrido C, Solary E, Dubrez-Daloz L. 2002. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 100: 4446-4453.
58. Soulet D, Rivest S. 2008. Microglia. Curr Biol 18: R506-R508.
59. Strasser A, Jost PJ, Nagata S. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30: 180-192.
60. Streit WJ. 2004. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 77: 1-8.
61. Takeda K, Akira S. 2004. TLR signaling pathways. Semin Immunol 16: 3-9.
62. Trinchieri G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
63. Turrel-Davin F, Guignant C, Lepape A, Mougin B, Monneret G, Venet F. 2010. Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients. Crit Care 14: R133.
64. Vela JM, Yanez A, Gonzalez B, Castellano B. 2002. Time course of proliferation and elimination of microglia/macrophages in different neurodegenerative conditions. J Neurotrauma 19: 1503-1520.
65. Yi CH, Yuan J. 2009. The Jekyll and Hyde functions of caspases. Dev Cell 16: 21-34.
66. Yin XM. 2006. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 369: 7-19.
67. Zhang X, Niessner A, Nakajima T, Ma-Krupa W, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. 2006. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res 98: 524-531.
68. Zinkel S, Gross A, Yang E. 2006. BCL2 family in DNA damage and cell cycle control. Cell Death Differ 13: 1351-1359.
69. Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ. 2005. A role for proapoptotic BID in the DNA-damage response. Cell 122: 579-591.